Cell Dissociation Market Size, Share, and COVID-19 Impact Analysis, By Method (Enzymatic Dissociation and Non-Enzymatic Dissociation), By Product (Instruments and Reagents & Consumables), By Application (Research, Diagnosis, and Others), By End-user (Pharmaceuticals and Biotechnology Companies, Research and Academic Institutes, and Others), and Regional Forecast, 2024-2032

Cell Dissociation is a basic technique for isolating cells from complex tissues. The targeted cells are identified and isolated according to their type. Cell dissociation or tissue dissociation are vital steps in several research applications, including creating vaccines, developing cancer treatments, biopsies, cell expansion, preservation of stem cells, etc.

Government organizations and leading biotechnological and pharmaceutical companies are raising research funds, thus increasing demand for cell isolation products. For instance, in November 2022, World Cancer Research Fund awarded USD 5.5 million to 19 new research projects working on cancer.

However, cell-based research is costlier as isolation and purification require expensive instruments. Such factors are limiting the adoption of products, thus hampering the market growth.

Impact of COVID-19 on the Cell Dissociation Market

The global cell dissociation market had a positive impact due to the COVID-19 pandemic. The growing research and development activities during the pandemic have led to new opportunities for the cell dissociation market.

• For instance, in December 2020, according to an article published in the National Library of Medicine, cell isolation was used to diagnose and assess treatments for covid-19.

Key Insights

• Prevalence of Cancer, By Key Countries, 2022.


• Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.).


• New Product Launches, By Key Players.


• Regulatory Scenario, By Key Countries/Region.


• Impact of COVID-19 on the Market.

Analysis by Product:

Based on the product, the cell dissociation market is segmented into enzymatic dissociation, and non-enzymatic dissociation. Enzymatic dissociation is expected to hold the dominant share of the market. In enzymatic dissociation, specific proteins are used to disaggregate cell culture samples. Selecting the correct cell dissociation enzyme makes the process extremely efficient. Maximum players have products in this category which justifies its demand and efficiency in the market. Its unique property of isolating the cells without damaging them increases its utility and promotes market growth.

For instance, in April 2022, according to an article published in Springer Nature Limited, accutase is gentle on cells. It can be used as a replacement for trypsin. Cellular dissociation can be done without damage using an accutase enzyme.

• For instance, Jennifer Smith, Ph.D., Postdoctoral Researcher, stated in UCSB that accutase is mild on cells and auto-inhibits at 37°C without a neutralizing solution like trypsin. Therefore simpler to use. Also, trypsin is cost-effective.

Regional Analysis:

Among the regions, North America gained the topmost position in the share and size of the global market. ­­The dominance of North America is attributed to significant product approvals from regulatory bodies and the strong presence of major biotech and pharmaceutical companies. Additionally, the rising prevalence of chronic diseases such as cancer favors the research for new drugs that predominantly include cell studies. Such trends are expected to increase product demand and drive market expansion.

• For instance, in 2020, FDA approved Haemonetics Corporation’s NexSys PCS with persona technology to use as an automated cell separator. Such product approvals are contributing to regional growth.

Key Players Covered

The report will include the profiles of key players such as Merck KGaA, Thermo Fisher Scientific, STEMCELL Technologies, Sartorius AG, BD (Becton, Dickinson and Company), PAN-Biotech, Otto Chemie Pvt. Ltd., Cytiva, HiMedia Laboratories, Worthington Biochemical Corporation, Cytori Therapeutics Inc., Miltenyi Biotec, and others.

Segmentation

Key Industry Developments

• October 2022: BD (Becton, Dickinson and Company) launched BD FACSDiscover S8 Cell Sorter. It is the first spectral flow cytometer sorter with sort-capable image analysis. It enables scientists to perform advanced flow cytometry while seeing the image of every single cell in real-time and then sorting them at high speed.


• September 2022: Thermo Fisher Scientific launched DynaSpin, a single-use centrifuge system for large-scale cell culture harvesting and separation with minimum use of depth filtration cartridges.


• April 2022: STEMCELL Technologies partnered with Applied Cells Inc. to create new high-performance cell separation solutions.